OTC Drug Ads Rarely Mention Risks, Study Finds

Law360, New York (September 12, 2012, 8:48 PM EDT) -- Drug advertisements referenced a treatment's risks far less frequently when it was sold over-the-counter than when it was sold by prescription, according to a study published Wednesday, a disparity that could be attributable to the different regulations governing the types of drugs.

A drug's potential harms were mentioned in 70 percent of the print and broadcast prescription-drug advertisements examined in a Journal of the American Medical Association study, but in just 11 percent of over-the-counter drug advertisements.

The U.S. Food and Drug Administration regulates advertisements for...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.